Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha-thalassemia.

J G Adams, M H Steinberg

    American Journal of Hematology
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    This review covers alpha-thalassemia, detailing its incidence, genetics, clinical features, and diagnosis. It also explores potential clinical uses of alpha-thalassemia molecular biology.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    HbF/F-cell and the Phenotype of Sickle Cell Disease.

    medRxiv : the preprint server for health sciences·2026
    Same author

    Mutations in the β-globin gene from a Saudi population: an update.

    International journal of laboratory hematology·2016
    Same author

    BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia.

    Blood cells, molecules & diseases·2015
    Same author

    Quantitative MRI analysis of craniofacial bone marrow in patients with sickle cell disease.

    AJNR. American journal of neuroradiology·2012
    Same author

    Clinical and radiologic findings of inner ear involvement in sickle cell disease.

    AJNR. American journal of neuroradiology·2011
    Same author

    Healing of Pseudointimas in Velour-lined, Impermeable Arterial Prostheses.

    The American journal of pathology·2009
    Same journal

    Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA.

    American journal of hematology·2026
    Same journal

    Comparative Efficacy of Intranasal, Intramuscular, and Intravenous Vitamin B12 Therapy for Hematological Recovery in Vitamin B12 Deficiency Anemia: A Randomized Controlled Trial.

    American journal of hematology·2026
    Same journal

    Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" Trial.

    American journal of hematology·2026
    Same journal

    Relapse Thresholds (12/24 Mo) Define Survival Disparity in Pediatric B-ALL.

    American journal of hematology·2026
    Same journal

    Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II Trial.

    American journal of hematology·2026
    Same journal

    Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation.

    American journal of hematology·2026
    See all related articles

    Area of Science:

    • Genetics
    • Hematology
    • Molecular Biology

    Background:

    • Alpha-thalassemia is a common inherited blood disorder.
    • Understanding its molecular basis is crucial for diagnosis and management.

    Purpose of the Study:

    • To review current knowledge on alpha-thalassemia.
    • To discuss the clinical applications of its molecular biology.

    Main Methods:

    • Literature review of existing studies on alpha-thalassemia.
    • Analysis of genetic and clinical data.
    • Exploration of molecular biology findings.

    Main Results:

    • Comprehensive overview of alpha-thalassemia's incidence, genetics, clinical spectrum, and diagnostic methods.
    • Discussion on the potential clinical utility of molecular insights.

    Conclusions:

    • Current understanding of alpha-thalassemia is well-established.
    • Molecular biology offers promising avenues for future clinical applications in managing alpha-thalassemia.